Home › Funds › ALETHEA CAPITAL MANAGEMENT, LLC › AXSM

ALETHEA CAPITAL MANAGEMENT, LLC position in AXSM

AXSOME THERAPEUTICS INC. · Health Care

ALETHEA CAPITAL MANAGEMENT, LLC reported holding 649,117 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$119.7M, representing 60.89% of its reported portfolio and ranking #1 among its reported holdings. ALETHEA CAPITAL MANAGEMENT, LLC has disclosed AXSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)649.12K sh
Reported value held$119.69M
Portfolio Weight60.89%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ALETHEA CAPITAL MANAGEMENT, LLC's AXSM position evolved

ALETHEA CAPITAL MANAGEMENT, LLC first disclosed a stake in AXSM in Q3 2023 at 758,794 shares (US$53.0M). The position peaked in Q2 2026 at 648,756 shares, worth US$158.8M. Across 13 filings, ALETHEA CAPITAL MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 649,117 shares valued at US$119.7M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 758.79K $53.03M New
Q4 2023 752.04K $59.86M Reduce
Q1 2024 740.79K $59.12M Reduce
Q2 2024 740.89K $59.64M Hold
Q3 2024 738.50K $66.37M Hold
Q4 2024 734.32K $62.13M Reduce
Q1 2025 667.37K $77.84M Reduce
Q2 2025 667.37K $69.67M Hold
Q3 2025 670.88K $81.48M Add
Q4 2025 668.71K $122.13M Hold
Q1 2026 649.11K $109.71M Reduce
Q2 2026 648.76K $158.80M Hold
Q3 2026 649.12K $119.69M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AXSM and 13F data

AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 49 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$171.3M), Hood River Capital Management LLC (US$98.6M), EVENTIDE ASSET MANAGEMENT, LLC (US$77.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AXSM

All AXSM fund holders →

FAQ

How long has ALETHEA CAPITAL MANAGEMENT, LLC held AXSM?

ALETHEA CAPITAL MANAGEMENT, LLC has disclosed AXSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ALETHEA CAPITAL MANAGEMENT, LLC's current position in AXSM?

As of Q3 2026, ALETHEA CAPITAL MANAGEMENT, LLC holds 649.12K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $119.69M, representing 60.89% of its reported portfolio and ranking #1.

Has ALETHEA CAPITAL MANAGEMENT, LLC been buying or selling AXSM?

In the latest 13F filing (Q3 2026), ALETHEA CAPITAL MANAGEMENT, LLC held unchanged its position in AXSM. The position peaked in Q2 2026 at 648.76K shares.

Which other funds hold AXSM?

Other major institutional holders of AXSM include Deep Track Capital, LP, Hood River Capital Management LLC, EVENTIDE ASSET MANAGEMENT, LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.